ADIPOQ and prostate carcinoma: No significant difference was observed in the androgen receptor positivity in the prostate cancer cells of the adiponectin < 6 μg/mL and leptin > 4 ng/mL group compared to the adiponectin > 6 μg/mL and leptin < 4 ng/mL group (p = 0.3696) (Supplementary Materials, Figure 1).